Advocating for cervical cancer prevention

• Published in: International journal of gynecology and obstetrics Vol. 89; no. S2; pp. S46 - S54
• Main Authors: Sherris, J., Agurto, I., Arrossi, S., Dzuba, I., Gaffikin, L., Herdman, C., Limpaphayom, K., Luciani, S.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Ireland Ltd 01.05.2005
• Subjects: Advocacy; Cervical cancer; Cervical Intraepithelial Neoplasia - prevention & control; Cost-Benefit Analysis; Developing Countries; Female; Global Health; Humans; Patient Advocacy - economics; Policy; Prevention; Program Development; Stakeholders; Uterine Cervical Neoplasms - prevention & control; Women's Health Services - economics; Prevention; Policy; Advocacy; Publications; Stakeholders; Cervical cancer
• ISSN: 0020-7292; 1879-3479
• DOI: 10.1016/j.ijgo.2005.01.010

Cervical cancer is a significant health problem among women in developing countries. Contributing to the cervical cancer health burden in many countries is a lack of understanding and political will to address the problem. Broad-based advocacy efforts that draw on research and program findings from developing-country settings are key to gaining program and policy support, as are cost-effectiveness analyses based on these findings. The Alliance for Cervical Cancer Prevention (ACCP) has undertaken advocacy efforts at the international, regional, national, and local levels to raise awareness and understanding of the problem (and workable solutions), galvanize funders and governments to take action, and engage local stakeholders in ensuring program success. ACCP experience demonstrates the role that evidence-based advocacy efforts play in the ultimate success of cervical cancer prevention programs, particularly when new screening and treatment approaches—and, ultimately, radically new approaches such as a human papillomavirus vaccine—are available.